EP1858490
Lyfjaform með endurbættum lyfjahvarfafræðilegum eiginleikum
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
16.2.2006EP published:
11.4.2012EP application number:
06706994.8
EP translation filed:
9.7.2012Grant published:
15.8.2012EPO information:
European Patent Register
Max expiry date:
15.2.2026Expiry date:
15.2.2026
Title:
PHARMACEUTICAL FORMS WITH IMPROVED PHARMACOKINETIC PROPERTIES
Timeline
Owner
Name:
Bayer Intellectual Property GmbHAddress:
Alfred-Nobel-Strasse 50, 40789, Monheim am Rhein, DE
Inventor
Name:
SERNO, PeterAddress:
Bergisch Gladbach, DE
Name:
HEINIG, RolandAddress:
Wuppertal, DE
Name:
PAULI, KerstinAddress:
Dortmund, DE
Name:
HAYAUCHI, YutakaAddress:
Leverkusen, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
102005009240Date:
1.3.2005Country:
DE
Classification
Categories:
A61K 9/22, A61K 31/53
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 25.1.2013
Expires: 15.2.2014
Payer: Sigurjónsson & Thor ehf.
Number: 9
Paid: 27.1.2014
Expires: 15.2.2015
Payer: Árnason Faktor
Number: 10
Paid: 27.1.2015
Expires: 15.2.2016
Payer: Árnason Faktor
Number: 11
Paid: 26.1.2016
Expires: 15.2.2017
Payer: Árnason Faktor
Number: 12
Paid: 27.1.2017
Expires: 15.2.2018
Payer: Árnason Faktor
Number: 13
Paid: 26.1.2018
Expires: 15.2.2019
Payer: Árnason Faktor
Number: 14
Paid: 24.1.2019
Expires: 15.2.2020
Payer: Árnason Faktor
Number: 15
Paid: 29.1.2020
Expires: 14.2.2021
Payer: Árnason Faktor ehf.
Number: 16
Paid: 29.1.2021
Expires: 15.2.2022
Payer: Árnason Faktor ehf.
Number: 17
Paid: 24.1.2022
Expires: 15.2.2023
Payer: Árnason Faktor ehf.
Number: 18
Paid: 24.1.2023
Expires: 15.2.2024
Payer: Árnason Faktor ehf.
Number: 19
Paid: 23.1.2024
Expires: 15.2.2025
Payer: Árnason Faktor ehf.
Number: 20
Paid: 27.1.2025
Expires: 15.2.2026
Payer: Árnason Faktor ehf.